SecBot SecBot
SC 13G ·Filed Oct 7, 2026

LCCC

Lakeshore Acquisition III Corp.
NEUTRAL
Impact 3/10
Horizondays Processed20d 4h ago SEC0001140361-26-038882
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any subsequent SC 13D conversion or business combination announcement from this SPAC, as multiple passive filings from multiple institutions (Barclays, W.R. Berkley, Feis Equities) suggest ongoing institutional interest but no active campaign.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
LCCC ▲ 0.00% at T+5d
NEUTRAL call 0.00% · α vs SPY +0.98% · entry $10.54 → $10.54
Next anchor: T+20d in 8d
Latest observation: T+12 -0.10% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.42%
$10.54
settled 19d ago
T+5d
0.00%
call 0.00% · α +0.98%
$10.54
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Wolverine Asset Management LLC disclosed a 5.21% passive stake in Lakeshore Acquisition III Corp. (a blank-check/SPAC), holding 199,222 ordinary shares as of September 30, 2026. This is a new 13G filing, not an amendment, and the investor certifies no intent to influence control. The filing adds to a pattern of passive institutional interest in this SPAC, following recent 13G filings by Barclays and W.R. Berkley, but provides no material financial or operational catalyst.

Key Financial Metrics

Stake
5.21%
Investor
Wolverine Asset Management LLC
Investor Type
hedge fund

Key Facts

  • Wolverine Asset Management LLC holds 199,222 ordinary shares of Lakeshore Acquisition III Corp.
  • Stake represents 5.21% of 3,822,787 outstanding shares (per issuer's August 5, 2026 10-Q).
  • Filed as a new Schedule 13G under Rule 13d-1(b) — passive investor with no intent to influence control.
  • Filing date: October 7, 2026, with date of change September 30, 2026.
  • Other reporting persons: Wolverine Holdings LLC, Christopher L. Gust, Robert R. Bellick also report 5.21% each.

Financial Impact

No financial impact — passive 5.21% stake with no operational change.

Risk Factors

  • No risk from this filing alone.
  • timeHorizon
  • drugNames

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001140361-26-038882
Document: 0001140361-26-038882-index.html0001140361-26-038882
Document: 0001140361-26-038882.txt0001140361-26-038882
3 reports for LCCC
Performance horizon
Filters
Rows
Reports for LCCC — sortable, filterable
TypeNow
Oct 7, 2026
20d ago
SC 13G
NEUTRAL ★ 3/10
$10.54awaiting T+20—$10.56 (+0.19%)
Sep 28, 2026
29d ago
8-K
NEUTRAL ★ 3/10
$10.52 $10.56▲ +0.38%▲ +0.41%$10.56 (+0.38%)
Sep 23, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$10.52 $10.55▲ +0.29%▼ −0.40%$10.56 (+0.38%)
Showing 3 of 3

US Market Status

Market Open — Closes in 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026